370 related articles for article (PubMed ID: 21674567)
1. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
2. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
4. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
[TBL] [Abstract][Full Text] [Related]
6. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
[TBL] [Abstract][Full Text] [Related]
7. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin.
Roth TM; Ramamurthy P; Muir D; Wallace MR; Zhu Y; Chang L; Barald KF
Dev Dyn; 2008 Feb; 237(2):513-24. PubMed ID: 18213578
[TBL] [Abstract][Full Text] [Related]
8. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1
Pennanen P; Peltonen S; Kallionpää RA; Peltonen J
Mol Cell Biochem; 2018 Jul; 444(1-2):27-33. PubMed ID: 29185159
[TBL] [Abstract][Full Text] [Related]
9. Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell.
Nakamura T; Nemoto T; Arai M; Yamazaki Y; Kasuga T; Gutmann DH; Collins FS; Ishikawa T
Am J Pathol; 1994 Mar; 144(3):549-55. PubMed ID: 8129040
[TBL] [Abstract][Full Text] [Related]
10. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
[TBL] [Abstract][Full Text] [Related]
11. Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone.
Overdiek A; Winner U; Mayatepek E; Rosenbaum T
Pediatr Res; 2008 Jul; 64(1):40-3. PubMed ID: 18360307
[TBL] [Abstract][Full Text] [Related]
12. Mucosal Schwann cell "hamartoma": clinicopathologic study of 26 neural colorectal polyps distinct from neurofibromas and mucosal neuromas.
Gibson JA; Hornick JL
Am J Surg Pathol; 2009 May; 33(5):781-7. PubMed ID: 19065103
[TBL] [Abstract][Full Text] [Related]
13. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
Wu M; Wallace MR; Muir D
J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
[TBL] [Abstract][Full Text] [Related]
15. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1.
Rutkowski JL; Wu K; Gutmann DH; Boyer PJ; Legius E
Hum Mol Genet; 2000 Apr; 9(7):1059-66. PubMed ID: 10767330
[TBL] [Abstract][Full Text] [Related]
16. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D
Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798
[TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
18. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
19. Identification of NF1 mutations in both alleles of a dermal neurofibroma.
Sawada S; Florell S; Purandare SM; Ota M; Stephens K; Viskochil D
Nat Genet; 1996 Sep; 14(1):110-2. PubMed ID: 8782831
[TBL] [Abstract][Full Text] [Related]
20. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis.
Badache A; Muja N; De Vries GH
Oncogene; 1998 Aug; 17(6):795-800. PubMed ID: 9715282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
